Skip to content

Study · Case report or series · n = 1 · 2019

1 result

Scientific report: a case of acute pancreatitis due to liraglutide.

Quesada-Vázquez N

Revista espanola de enfermedades digestivas1 Apr 2019Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesSafety outcome

    In a 44-year-old woman, a case of acute pancreatitis was attributed to liraglutide therapy.

    In plain wordsIn one 44-year-old woman, the authors linked a case of acute pancreatitis to liraglutide. One case cannot show how often this happens.

    Outcome
    IncreaseAcute pancreatitis
    Study

    n = 1

    Outcome group
    Gastrointestinal adverse events · Gastrointestinal
    Studied dose
    Dose not stated

    Source sentences

    Title
    Scientific report: a case of acute pancreatitis due to liraglutide.
    1 context sentence
    Summary · context
    This case reported herein was a 44-year-old female diagnosed with acute pancreatitis based on 2 of 3 criteria when she presented to the Emergency Department with epigastric pain, which radiated to her back.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 11:11 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.